The Caring Ambassadors supports individuals in gaining control of their health care, regardless of the illness they face.
We provide information, tools, and resources to help those with any chronic health condition not only manage their health care after a diagnosis, but improve their quality of life and capacity for healing.
As an advocacy organization, we both fight for patient rights and work to build a new generation of patient and health care champions.
Our disease specific programs for Hepatitis C and Lung Cancer have been helping people obtain the support, assistance, and information they need for over 20 years.
The Caring Ambassadors Lung Cancer Program provides this website to help you and your loved ones understand your disease and some of the health care options available to you.
Knowledge empowers you to ask the necessary questions to become your own best advocate.
The Caring Ambassadors Hepatitis C Program uses a unique approach in our work to address the elimination of viral hepatitis and specifically hepatitis C.
We are honored to serve the community to help eliminate the largest infectious disease outbreak of our time
MY CHOICES© is a tool to help you recognize and act upon what you can control in your health care journey to achieve optimal healing, regardless of the illness you face. It contains elements of a guide book, health planner, journal, and activity book to help orient you to and plan for the journey ahead.
AmazonSmile is a website operate by Amazon with the same products, prices and shopping features as Amazon.com. The difference is that when you shop on AmazonSmile, the AmazonSmile Foundation will donate 0.5% of the purchase price of eligible products.
The time is now. 71 million people worldwide are living with chronic Hepatitis C right now. It is the largest chronic infectious disease outbreak of our time…and it’s curable. Talk to your doctor about treatment for your Hepatitis C, and don’t take no for an answer
Weekly News Update.
Caring Ambassadors Program provides 3 weekly news updates covering Lung Cancer News, Hepatitis C News, and My Choices© Update. Receive them delivered weekly to your inbox.
My Choices© Update
Week Ending January 20, 2020
Dr. Mary Ann Osborne of the Institute For Integral Health to be Featured on Close Up Radio
“Hippocrates the ancient Greek physician famously said, “The natural healing force within each one of us is the greatest force in getting well.” How true is it today that we actually possess a holistic mind set regarding our health?”
Implementing post-genomic personalized medicine: The rise of glycan biomarkers
“An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers.”
6 Science-Backed Benefits of Probiotics & Who Should Take Them
“The microbiome, the collection of bacteria living in the gut, plays an integral role in overall health. Two of the most popular ways to take care of your gut and give it the support it needs are probiotic supplements and probiotic-rich foods, like yogurt and kimchi. Here, we’ll dive into what exactly probiotics can do for you, your gut, and your overall health.”
What are the benefits of high intensity interval training (HIIT)?
“Although it is common knowledge that exercise provides benefits, many people can find it difficult to find time for regular physical activity.”
Start Fresh: 6 Tips For Emotional Well-Being In 2020
“If you’re trying to get a new routine to stick — whether it’s getting more exercise, eating less sugar or learning to play the ukulele — scholars who study human behavior say the key is to accept failure as a part of the process.”
Easing into exercise
“Are you one of those people whose typical day includes doing chores around the house and yard, running errands, and caring for a spouse, grandkids, or pets?”
Humor and Health: The Surprising Connection
“Let’s be honest, there are few things better in this world than laughing your ass off. We all know from experience that just having a good laugh can instantly improve our mindset and generally improve our mood. Surprisingly, there is actually a boatload of measurable health benefits to a good laughing fit.”
Study Finds Exercise Can Boost Memory & Fight Caffeine Withdrawal
“Thinking about quitting caffeine but worried about the adverse effects? Researchers may have found a quick (and multi-beneficial) way to boost memory without caffeine. A recent study published in Nature Scientific Reports found that as little as 20 minutes of exercise can boost your memory as well as, or even better than, a cup of coffee.”
Hepatitis C News
Week Ending January 20, 2020
No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
‘A new retrospective study out of Asia was not able to confirm an association between hepatitis C virus (HCV) infection and risk for extrahepatic malignancies. According to the study, several studies have shown that HCV may infect organs and tissue outside of the liver, and has been implicated in extrahepatic malignancies such as non-Hodgkin lymphoma (NHL), cholangiocarcinoma, pancreatic cancer, and oral carcinomas.’
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: A nationwide cohort study
‘A nationwide cohort study was performed to correlate the occurrence rates of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) carriers treated with or without aspirin. A sum of 2,980 aspirin-treated HCV carriers and 7,771 non-aspirin-treated HCV carriers were included in Taiwan between 2000 and 2012.’
Mandated hep C treatment for SC inmates gets initial consent
’A federal judge granted preliminary approval Tuesday of a proposed settlement mandating testing and treatment for hepatitis C of all inmates in South Carolina correction facilities. Plaintiffs Russell Geissler, Bernard Bagley and Willie James Jackson filed a lawsuit in 2017 against the Department of Corrections over a lack of treatment for hepatitis C.’
Mental and Cognitive Impairment in Hepatitis C Virus
‘Although the care of patients with hepatitis C virus (HCV) infection has radically improved since the US Food and Drug Administration approved the first direct-acting antiviral medication for HCV treatment in 2013, the burden associated with the disease remains high, and the opioid epidemic has led to a surge in new cases.’
Global prevalence of hepatitis C virus in children in 2018: a modelling study
‘Hepatitis C virus (HCV) prevalence estimates for adults and high-risk groups have been widely published, but the disease burden in children is poorly understood. Direct-acting antiviral drugs, which are considered to be highly effective curative therapies for HCV, are now approved for paediatric patients as young as 3 years.’
‘Major milestone’: Governor’s budget targets hepatitis C epidemic in prisons
‘Nearly half of the people in New Mexico’s state prisons are infected with hepatitis C, and for years, the Corrections Department has only purchased enough medicine to treat a fraction of them. But that may be about to change. The executive budget proposal Gov. Michelle Lujan Grisham released Jan. 6 recommends $30 million in new funding for the Corrections Department for treatment of hepatitis C, with the expectation of curing most inmates by the end of 2024.’
Hepatitis D coinfection found in ‘household clusters’ in Cameroon
‘Investigation into the epidemiology of hepatitis D in Cameroon revealed intrahousehold infection and large differences in prevalence between regions, with cases concentrated in forested areas close to the equator, which has been seen in other tropical areas.’
New CA Bill to End the Epidemics of HIV, Hepatitis C and Other STDs in LGBTQ+ Community
‘Senator Scott Wiener (D-San Francisco) recently introduced a bill that would require state agencies to create and enforce a master plan to end new infections of HIV, hepatitis C and other STIs. All three diseases disproportionately impact gay and bisexual men, African American men and people ages 15-24, according to the Center for Disease Control. “We have the tools to end new infections of HIV and STDs. What we’re missing is political will.’
Lung Cancer News
Week Ending January 20, 2020
Lung screening program offered at Piedmont ARMC
“Piedmont Athens Regional Medical Center offers a lung screening program for patients who meet a criteria and are deemed “high risk” for lung cancer, which makes them eligible to participate.”
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
“SEONGNAM, South Korea, Jan. 19, 2020 /PRNewswire/ — Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared on January 18th.”
JCPHS reminds public to test homes for radon, offers free detectors
“WATERTOWN — January is National Radon Action Month, and the Jefferson County Public Health Service is reminding residents to test their homes for the invisible, odorless and tasteless gas.”
Dana-Farber Cancer Institute to Establish Chen-Huang Center for EGFR Mutant Lung Cancers
“The Dana-Farber Cancer Institute in Boston, Massachusetts, announced that the Chen-Huang Center for EGFR Mutant Lung Cancers is being established with a gift of $5 million from Winston Chen, PhD, and his wife Phyllis Huang, according to a press release. The center will help in the development of research and clinical trials, as well as improve upon the treatment of patients with EGFR-mutated lung cancer at Dana-Farber.“
Celecoxib Added to Concurrent Chemoradiation Not Effective for Patients with NSCLC
“A phase II randomized study failed to demonstrate the value of adding celecoxib (Celebrex) to concurrent chemoradiation (CCCRT) for patients with unresectable, inoperable, locally advanced non-small cell lung cancer (NSCLC), according to a report published in JAMA Network Open.”
Now recruiting: Combination therapy clinical trial for small-cell lung or small-cell extrapulmonary cancers
“Patients with small-cell lung cancer that has returned after treatment or small-cell cancer that started outside the lungs may be eligible to participate in a clinical trial at the NIH Clinical Center”
FDA grants fast review to BMS’ first-line lung cancer combo.
“Bristol-Myers Squibb has finally made its bid for a slice of the lucrative first-line lung non-small cell lung cancer (NSCLC) market, after the FDA agreed to quickly review trial results from its two-drug immunotherapy combination.”